Skip to main content
Log in

Therapie von hypertrophen Narben und Keloiden

Ein Update

Keloid and hypertrophic scar treatment modalities

An update

  • CME Zertifizierte Fortbildung
  • Published:
Der Chirurg Aims and scope Submit manuscript

Zusammenfassung

In der Behandlung von hypertrophen Narben und Keloiden haben sich in den letzten 20 Jahren neue Verfahren etabliert, die zum Teil auf einer Verbesserung bewährter Methoden beruhen, aber auch als komplette Neuentwicklungen den Weg in die Praxis gefunden haben. In diesem Übersichtsartikel wird zunächst kurz der Stand der aktuellen Forschung im Hinblick auf die multifaktorielle Ätiologie der Narbenbildung dargestellt. Wir skizzieren weiterhin die Grundlagen möglicher Narbentherapien, erklären die Unterschiede zwischen konservativen und chirurgischen Behandlungsansätzen und geben eine Ausblick auf neuartige Optionen auf dem Gebiet der Narbenbehandlung.

Abstract

Over the past two decades the treatment of hypertrophic scars and keloids has seen substantial changes due to the evolution of current and establishment of new conservative and surgical methods. This review gives an overview of the current research with respect to the multifactorial etiology and pathophysiology of keloids and hypertrophic scars, discusses conservative surgical treatment options and provides an outlook on novel treatment strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6
Abb. 7
Abb. 8
Abb. 9

Literatur

  1. Werner S Grose R (2003) Regulation of wound healing by growth factors and cytokines. Physiol Rev 83:835–870

    PubMed  CAS  Google Scholar 

  2. Clark RAF (Hrsg) (1996) The molecular and cellular biology of wound repair. 2 Aufl. Plenum, New York, S 3–50

  3. Singer AJ, Clark RA (1999) Cutaneous wound healing. N Engl J Med 341:738–746

    Article  PubMed  CAS  Google Scholar 

  4. Eming SA, Krieg T, Davidson JM (2004) Gene transfer in tissue repair: status, challenges and future directions. Expert Opin Biol Ther 4:1373–1386

    Article  PubMed  CAS  Google Scholar 

  5. Mustoe TA (2004) Scars and keloids. BMJ 328:1329–1330

    Article  PubMed  Google Scholar 

  6. Slemp AE, Kirschner RE (2006) Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr 18:396–402

    Article  PubMed  Google Scholar 

  7. Berman B et al (2007) A review of the biologic effects, clinical efficacy, and safety of silicone elastomer sheeting for hypertrophic and keloid scar treatment and management. Dermatol Surg 33:1291–1303

    Article  PubMed  CAS  Google Scholar 

  8. Linares HA, Larson DL, Willis-Galstaun BA (1993) Historical notes on the use of pressure in the treatment of hypertrophic scars or keloids. Burns 19:17–21

    Article  PubMed  CAS  Google Scholar 

  9. Engrav LH et al (2010) 12-Year within-wound study of the effectiveness of custom pressure garment therapy. Burns 36:975–983

    Article  PubMed  CAS  Google Scholar 

  10. Shin TM, Bordeaux JS (2012) The role of massage in scar management: a literature review. Dermatol Surg 38:414–423

    Article  PubMed  CAS  Google Scholar 

  11. Juckett G, Hartman-Adams H (2009) Management of keloids and hypertrophic scars. Am Fam Physician 80:253–260

    PubMed  Google Scholar 

  12. Quinn KJ (1987) Silicone gel in scar treatment. Burns Incl Therm Inj 13(Suppl):33–40

    Article  Google Scholar 

  13. Gold MH (1994) A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J Am Acad Dermatol 30:506–507

    Article  PubMed  CAS  Google Scholar 

  14. O’Brien L, Pandit A (2006) Silicon gel sheeting for preventing and treating hypertrophic and keloid scars. Cochrane Database Syst Rev 1:CD003826

    Google Scholar 

  15. Alster TS, Tanzi EL (2003) Hypertrophic scars and keloids: etiology and management. Am J Clin Dermatol 4:235–243

    Article  PubMed  Google Scholar 

  16. Boutli-Kasapidou F et al (2005) Hypertrophic and keloidal scars: an approach to polytherapy. Int J Dermatol 44:324–327

    Article  PubMed  Google Scholar 

  17. Mofikoya BO, Adeyemo WL, Abdus-salam AA (2007) Keloid and hypertrophic scars: a review of recent developments in pathogenesis and management. Nig Q J Hosp Med 17:134–139

    PubMed  Google Scholar 

  18. Rusciani L et al (2006) Cryotherapy in the treatment of keloids. J Drugs Dermatol 5:591–595

    PubMed  CAS  Google Scholar 

  19. Zouboulis CC et al (1993) Outcomes of cryosurgery in keloids and hypertrophic scars. A prospective consecutive trial of case series. Arch Dermatol 129:1146–1151

    Article  PubMed  CAS  Google Scholar 

  20. Ogawa R et al (2009) Is radiation therapy for keloids acceptable? The risk of radiation-induced carcinogenesis. Plast Reconstr Surg 124:1196–1201

    Article  PubMed  CAS  Google Scholar 

  21. Ogawa R et al (2007) Postoperative radiation protocol for keloids and hypertrophic scars: statistical analysis of 370 sites followed for over 18 months. Ann Plast Surg 59:688–691

    Article  PubMed  CAS  Google Scholar 

  22. Niessen FB et al (1999) On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 104:1435–1458

    Article  PubMed  CAS  Google Scholar 

  23. Darzi MA et al (1992) Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study. Br J Plast Surg 45:374–379

    Article  PubMed  CAS  Google Scholar 

  24. Al-Attar A et al (2006) Keloid pathogenesis and treatment. Plast Reconstr Surg 117:286–300

    Article  PubMed  CAS  Google Scholar 

  25. Graham GF (1993) Cryosurgery. Clin Plast Surg 20:131–147

    PubMed  CAS  Google Scholar 

  26. Lahiri A, Tsiliboti D, Gaze NR (2001) Experience with difficult keloids. Br J Plast Surg 54:633–635

    Article  PubMed  CAS  Google Scholar 

  27. Kiil J (1977) Keloids treated with topical injections of triamcinolone acetonide (kenalog). Immediate and long-term results. Scand J Plast Reconstr Surg 11:169–172

    Article  PubMed  CAS  Google Scholar 

  28. Asilian A., Darougheh A, Shariati F (2006) New combination of triamcinolone, 5-Fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg 32:907–915

    Article  PubMed  CAS  Google Scholar 

  29. Manuskiatti W, Fitzpatrick RE (2002) Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol 138:1149–1155

    Article  PubMed  CAS  Google Scholar 

  30. Fitzpatrick RE (1999) Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 25:224–232

    Article  PubMed  CAS  Google Scholar 

  31. Gupta S, Kalra A (2002) Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids. Dermatology 204:130–132

    Article  PubMed  CAS  Google Scholar 

  32. Haurani MJ et al (2009) 5-Fluorouracil treatment of problematic scars. Plast Reconstr Surg 123:139–149

    Article  PubMed  CAS  Google Scholar 

  33. Nanda S, Reddy BS (2004) Intralesional 5-fluorouracil as a treatment modality of keloids. Dermatol Surg 30:54–57

    Article  PubMed  Google Scholar 

  34. Uppal RS et al (2001) The effects of a single dose of 5-fluorouracil on keloid scars: a clinical trial of timed wound irrigation after extralesional excision. Plast Reconstr Surg 108:1218–1224

    Article  PubMed  CAS  Google Scholar 

  35. Espana A, Solano T, Quintanilla E (2001) Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol Surg 27:23–27

    Article  PubMed  CAS  Google Scholar 

  36. Lee RC, Ping JA (1990) Calcium antagonists retard extracellular matrix production in connective tissue equivalent. J Surg Res 49:463–466

    Article  PubMed  CAS  Google Scholar 

  37. D’Andrea F et al (2002) Prevention and treatment of keloids with intralesional verapamil. Dermatology 204:60–62

    Article  Google Scholar 

  38. Aerztezeitung. Off-Label-Use. 2009 [cited 2012 April 23]; Available from: http://www.aerztezeitung.de/politik_gesellschaft/gp_specials/abc_gesundheitswesen/article/564719/off-label-use.html

  39. Tierney EP, Hanke CW (2010) Review of the literature: treatment of dyspigmentation with fractionated resurfacing. Dermatol Surg 36:1499–1508

    Article  PubMed  CAS  Google Scholar 

  40. Ross RB, Spencer J (2008) Scarring and persistent erythema after fractionated ablative CO2 laser resurfacing. J Drugs Dermatol 7:1072–1073

    PubMed  Google Scholar 

  41. Rao J (2011) Treatment of acne scarring. Facial Plast Surg Clin North Am 19:275–291

    Article  PubMed  Google Scholar 

  42. Haedersdal M et al (2010) Fractional CO(2) laser-assisted drug delivery. Lasers Surg Med 42:113–122

    Article  PubMed  Google Scholar 

  43. Steiert AE (2011) Laserchirurgie. In: Vogt PM (Hrsg) Praxis der Plastischen Chirurgie. Springer, Berlin, S 34–38

  44. Gohritz A, Vogt PM (2011) Grundtechniken der Nahlappenplastiken zur Rekonstruktion im Gesicht. In: Vogt PM (Hrsg) Praxis der Plastischen Chirurgie. Springer, Berlin, S 113–121

  45. Fernandes D (2002) Percutaneous collagen induction: an alternative to laser resurfacing. Aesthet Surg J 22:307–309

    Article  PubMed  Google Scholar 

  46. Aust MC et al (2010) Percutaneous collagen induction therapy: an alternative treatment for burn scars. Burns 36:836–843

    Article  PubMed  Google Scholar 

  47. Aust MC et al (2008) Percutaneous collagen induction: minimally invasive skin rejuvenation without risk of hyperpigmentation-fact or fiction? Plast Reconstr Surg 122:1553–1563

    Article  PubMed  CAS  Google Scholar 

  48. Burke JF et al (1981) Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 194:413–428

    Article  PubMed  CAS  Google Scholar 

  49. Heimbach DM et al (2003) Multicenter postapproval clinical trial of Integra dermal regeneration template for burn treatment. J Burn Care Rehabil 24:42–48

    Article  PubMed  Google Scholar 

  50. Branski LK et al (2007) Longitudinal assessment of Integra in primary burn management: a randomized pediatric clinical trial. Crit Care Med 35:2615–2623

    Article  PubMed  Google Scholar 

  51. Ryssel H et al (2008) The use of MatriDerm in early excision and simultaneous autologous skin grafting in burns – a pilot study. Burns 34:93–97

    Article  PubMed  CAS  Google Scholar 

  52. Ryssel H et al (2010) Dermal substitution with Matriderm® in burns on the dorsum of the hand. Burns 36:1248–1253

    Article  PubMed  CAS  Google Scholar 

  53. Ryssel H et al (2010) Single-stage Matriderm® and skin grafting as an alternative reconstruction in high-voltage injuries. Int Wound J 7:385–392

    Article  PubMed  Google Scholar 

  54. Saour S, Atkins J, Healy CM (2009) Novel method of applying Matriderm and SSG as a composite unit, improving accuracy, speed and adherence to the recipient site. J Plast Reconstr Aesthet Surg 62:e77

    Article  PubMed  CAS  Google Scholar 

  55. Schneider J et al (2009) Matriderm versus Integra: a comparative experimental study. Burns 35:51–57

    Article  PubMed  Google Scholar 

  56. Haslik W et al (2010) Management of full-thickness skin defects in the hand and wrist region: first long-term experiences with the dermal matrix Matriderm. J Plast Reconstr Aesthet Surg 63:360–364

    Article  PubMed  CAS  Google Scholar 

  57. Ogawa R (2010) The most current algorithms for the treatment and prevention of hypertrophic scars and keloids. Plast Reconstr Surg 125:557–568

    Article  PubMed  CAS  Google Scholar 

  58. Ehrlich HP et al (1994) Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 145:105–113

    PubMed  CAS  Google Scholar 

  59. Burd A, Huang L (2005) Hypertrophic response and keloid diathesis: two very different forms of scar. Plast Reconstr Surg 116:150e–157e

    Article  PubMed  Google Scholar 

  60. Vogt PM (Hrsg) (2011) Praxis der Plastischen Chirurgie. Springer, Berlin

Download references

Interessenkonflikt

Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P.M. Vogt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Branski, L., Rennekampff, H. & Vogt, P. Therapie von hypertrophen Narben und Keloiden. Chirurg 83, 831–846 (2012). https://doi.org/10.1007/s00104-011-2243-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00104-011-2243-0

Schlüsselworter

Keywords

Navigation